ZECCA, LUIGI
ZECCA, LUIGI
Istituto di Tecnologie Biomediche - ITB
A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease
2006 Zecca, L; Zucca, Fa; Albertini, A; Rizzio, E; Fariello, Rg
Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease.
2003 Wilms, H; Rosenstiel, P; Sievers, J; Deuschl, G; Zecca, L; Lucius, R
Aluminium in Alzheimer's disease: are we still at a crossroad?
2005 Gupta V.B.; Anitha S.; Hegde M.L.; Zecca L.; Garruto R.M.; Ravid R.; Shankar S.K.; Stein R.; Shanmugavelu P.; Jagannatha Rao K.S.
Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference.
2006 Rao K.S.; Hegde M.L.; Anitha S.; Musicco M.; Zucca F.A.; Turro N.J.; Zecca L.
An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs.
2010 Crippa, Pr; Eisner, M; Morante, S; Stellato, F; Vicentin, Fc; Zecca, L
Biosynthetic pathway to neuromelanin and its aging process
2012 Wakamatsu, K; Murase, T; Zucca, Fa; Zecca, L; Ito, S
Brain iron pathways and their relevance to Parkinson's disease.
2001 Berg D.; Gerlach M.; Youdim M.B.H.; Double K.L.; Zecca L.; Riederer P.; Becker G.
Challenges associated with metal chelation therapy in Alzheimer's disease.
2009 Hegde, Ml; Bharathi, P; Suram, A; Venugopal, C; Jagannathan, R; Poddar, P; Srinivas, P; Sambamurti, K; Rao, Kj; Scancar, J; Messori, L; Zecca, L; Zatta, P
Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra
2001 Zecca L.; Tampellini D.; Costi P.; Rizzio E.; Giaveri G.; Gallorini M.
Contrast mechanisms associated with neuromelanin-MRI
2017 Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A.
COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside
2020 Sulzer D; Antonini A; Leta V; Nordvig A; Smeyne RJ; Goldman JE; AlDalahmah O; Zecca L; Sette A; Bubacco L; Meucci O; Moro E; Harms AS; Xu Y; Fahn S; Ray Chaudhuri K
DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease
2023 Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X
Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases
2019 Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L
Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry
2016 Biesemeier, A; Eibl, O; Eswara, S; Audinot, Jn; Wirtz, T; Pezzoli, G; Zucca, Fa; Zecca, L; Schraermeyer, U
Engineered nanoparticles. How brain friendly is this new guest?
2014 Cupaioli F.A.; Zucca F.A.; Boraschi D.; Zecca L.
Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI
2020 Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi Dargham A; Martinez D; Horga G
Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells
2021 Sulkowski M.; Kot M.; Badyra B.; Paluszkiewicz A.; Plonka P.M.; Sarna M.; MichalczykWetula D.; Zucca F.A.; Zecca L.; Majka M.
Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons
2012 Bachis, A; Avdoshina, V; Zecca, L; Parsadanian, M; Mocchetti, I
Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease
2008 Zecca L.; Wilms H.; Geick S.; Claasen J.H.; Brandenburg L.O.; Holzknecht C.; Panizza M.L.; Zucca F.A.; Deuschl G.; Sievers J.; Lucius R.
Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death.
2013 Zhang, W; Zecca, L; Wilson, B; Ren, Hw; Wang, Yj; Wang, Xm; Hong, Js
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| A proposed dual role of neuromelanin in the pathogenesis of Parkinson's disease | 1-gen-2006 | Zecca, L; Zucca, Fa; Albertini, A; Rizzio, E; Fariello, Rg | |
| Activation of microglia by human neuromelanin is NF-kappaB dependent and involves p38 mitogen-activated protein kinase: implications for Parkinson's disease. | 1-gen-2003 | Wilms, H; Rosenstiel, P; Sievers, J; Deuschl, G; Zecca, L; Lucius, R | |
| Aluminium in Alzheimer's disease: are we still at a crossroad? | 1-gen-2005 | Gupta V.B.; Anitha S.; Hegde M.L.; Zecca L.; Garruto R.M.; Ravid R.; Shankar S.K.; Stein R.; Shanmugavelu P.; Jagannatha Rao K.S. | |
| Amyloid beta and neuromelanin--toxic or protective molecules? The cellular context makes the difference. | 1-gen-2006 | Rao K.S.; Hegde M.L.; Anitha S.; Musicco M.; Zucca F.A.; Turro N.J.; Zecca L. | |
| An XAS study of the sulfur environment in human neuromelanin and its synthetic analogs. | 1-gen-2010 | Crippa, Pr; Eisner, M; Morante, S; Stellato, F; Vicentin, Fc; Zecca, L | |
| Biosynthetic pathway to neuromelanin and its aging process | 1-gen-2012 | Wakamatsu, K; Murase, T; Zucca, Fa; Zecca, L; Ito, S | |
| Brain iron pathways and their relevance to Parkinson's disease. | 1-gen-2001 | Berg D.; Gerlach M.; Youdim M.B.H.; Double K.L.; Zecca L.; Riederer P.; Becker G. | |
| Challenges associated with metal chelation therapy in Alzheimer's disease. | 1-gen-2009 | Hegde, Ml; Bharathi, P; Suram, A; Venugopal, C; Jagannathan, R; Poddar, P; Srinivas, P; Sambamurti, K; Rao, Kj; Scancar, J; Messori, L; Zecca, L; Zatta, P | |
| Combined biochemical separation and INAA for the determination of iron and other metals in Neuromelanin of human brain Substantia Nigra | 1-gen-2001 | Zecca L.; Tampellini D.; Costi P.; Rizzio E.; Giaveri G.; Gallorini M. | |
| Contrast mechanisms associated with neuromelanin-MRI | 1-gen-2017 | Trujillo P.; Summers P.E.; Ferrari E.; Zucca F.A.; Sturini M.; Mainardi L.T.; Cerutti S.; Smith A.K.; Smith S.A.; Zecca L.; Costa A. | |
| COVID-19 and possible links with Parkinson's disease and parkinsonism: from bench to bedside | 1-gen-2020 | Sulzer D; Antonini A; Leta V; Nordvig A; Smeyne RJ; Goldman JE; AlDalahmah O; Zecca L; Sette A; Bubacco L; Meucci O; Moro E; Harms AS; Xu Y; Fahn S; Ray Chaudhuri K | |
| DOPA pheomelanin is increased in nigral neuromelanin of Parkinson's disease | 1-gen-2023 | Cai, W; Wakamatsu, K; Zucca, Fa; Wang, Q; Yang, K; Mohamadzadehonarvar, N; Srivastava, P; Tanaka, H; Holly, G; Casella, L; Ito, S; Zecca, L; Chen, X | |
| Dopamine, Oxidative Stress and Protein-Quinone Modifications in Parkinson's and Other Neurodegenerative Diseases | 1-gen-2019 | Monzani, E; Nicolis, S; Dell'Acqua, S; Capucciati, A; Bacchella, C; Zucca, Fa; Mosharov, Ev; Sulzer, D; Zecca, L; Casella, L | |
| Elemental mapping of Neuromelanin organelles of human Substantia Nigra: correlative ultrastructural and chemical analysis by analytical transmission electron microscopy and nano-secondary ion mass spectrometry | 1-gen-2016 | Biesemeier, A; Eibl, O; Eswara, S; Audinot, Jn; Wirtz, T; Pezzoli, G; Zucca, Fa; Zecca, L; Schraermeyer, U | |
| Engineered nanoparticles. How brain friendly is this new guest? | 1-gen-2014 | Cupaioli F.A.; Zucca F.A.; Boraschi D.; Zecca L. | |
| Evidence for Dopamine Abnormalities in the Substantia Nigra in Cocaine Addiction Revealed by Neuromelanin-Sensitive MRI | 1-gen-2020 | Cassidy CM; Carpenter KM; Konova AB; Cheung V; Grassetti A; Zecca L; Abi Dargham A; Martinez D; Horga G | |
| Highly Effective Protocol for Differentiation of Induced Pluripotent Stem Cells (iPS) into Melanin-Producing Cells | 1-gen-2021 | Sulkowski M.; Kot M.; Badyra B.; Paluszkiewicz A.; Plonka P.M.; Sarna M.; MichalczykWetula D.; Zucca F.A.; Zecca L.; Majka M. | |
| Human immunodeficiency virus type 1 alters brain-derived neurotrophic factor processing in neurons | 1-gen-2012 | Bachis, A; Avdoshina, V; Zecca, L; Parsadanian, M; Mocchetti, I | |
| Human neuromelanin induces neuroinflammation and neurodegeneration in the rat substantia nigra: implications for Parkinson's disease | 1-gen-2008 | Zecca L.; Wilms H.; Geick S.; Claasen J.H.; Brandenburg L.O.; Holzknecht C.; Panizza M.L.; Zucca F.A.; Deuschl G.; Sievers J.; Lucius R. | |
| Human neuromelanin: an endogenous microglial activator for dopaminergic neuron death. | 1-gen-2013 | Zhang, W; Zecca, L; Wilson, B; Ren, Hw; Wang, Yj; Wang, Xm; Hong, Js |